Can Co-stimulated Tumor Immunity be Therapeutically Efficacious?
- 1 June 1995
- journal article
- Published by Wiley in Immunological Reviews
- Vol. 145 (1), 123-145
- https://doi.org/10.1111/j.1600-065x.1995.tb00079.x
Abstract
No abstract availableThis publication has 86 references indexed in Scilit:
- Expression of the co‐stimulatory molecule B7 on melanoma cellsInternational Journal of Cancer, 1994
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Tumor-Specific Immune Responses and Opportunities for Tumor VaccinesClinical Immunology and Immunopathology, 1994
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- Natural history of HLA expression during tumour developmentImmunology Today, 1993
- The Role of the CD28 Receptor During T Cell Responses To AntigensAnnual Review of Immunology, 1993
- Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathwayImmunology Today, 1991
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformationNature, 1984
- Suppressor mechanisms in tumor immunityCellular and Molecular Life Sciences, 1983